Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||||||
| Cash income from operating activities | -71.87%11.87M | 28.95%42.19M | 646.36%32.72M | -174.96%-5.99M | -2.06%7.99M | -73.74%8.16M | 43.04%31.05M | 531.84%21.71M | 1,251.35%3.44M | |
| Revenue from customers | ---- | -71.87%11.87M | 29.28%42.19M | 865.44%32.63M | -54.81%3.38M | -8.29%7.48M | -73.74%8.16M | 43.04%31.05M | 531.84%21.71M | --3.44M |
| Other cash income from operating activities | ---- | ---- | ---- | 100.90%84K | -1,944.09%-9.37M | --508K | ---- | ---- | ---- | ---- |
| Cash paid | -32.42%-10.82M | 78.09%-8.17M | -21.58%-37.3M | -167.58%-30.68M | 17.40%-11.47M | 6.93%-13.88M | 11.04%-14.92M | 28.85%-16.77M | -189.81%-23.57M | -109.25%-8.13M |
| Payments to suppliers for goods and services | -32.42%-10.82M | 78.09%-8.17M | -21.58%-37.3M | -167.58%-30.68M | 17.40%-11.47M | 6.93%-13.88M | 11.04%-14.92M | 28.85%-16.77M | -189.81%-23.57M | -126.65%-8.13M |
| Direct interest paid | ---1K | ---- | 66.67%-1K | 97.83%-3K | 93.04%-138K | -937.70%-1.98M | 76.65%-191K | -60.39%-818K | -1,086.05%-510K | -114,313.35%-43K |
| Direct interest received | 77.56%1.98M | 663.01%1.11M | 1,227.27%146K | -26.67%11K | -71.70%15K | -71.96%53K | 127.71%189K | 418.75%83K | -63.64%16K | -68.97%44K |
| Direct tax refund paid | ---- | ---- | ---- | ---- | 242.72%294K | -28.75%-206K | ---160K | ---- | ---- | ---- |
| Operating cash flow | -283.88%-8.84M | -4.39%4.81M | 146.21%5.03M | 111.82%2.04M | -115.26%-17.28M | -15.99%-8.03M | -151.08%-6.92M | 676.44%13.55M | 49.93%-2.35M | -25.38%-4.7M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -148.86%-81.86M | -169.96%-32.89M | -1,130.71%-12.18M | -410.31%-990K | -252.73%-194K | -103.28%-55K | 125.90%1.68M | 41.64%-6.48M | 68.75%-11.1M | -110.19%-35.53M |
| Capital expenditure reported | ---- | ---- | ---- | ---- | 91.14%-21K | 78.74%-237K | 64.12%-1.12M | -177.01%-3.11M | 95.91%-1.12M | -145.84%-27.42M |
| Net PPE purchase and sale | -148.86%-81.86M | -171.72%-32.89M | -1,145.37%-12.11M | -503.73%-972K | -224.81%-161K | 22.86%129K | 129.66%105K | 96.45%-354K | -34.47%-9.98M | -61.78%-7.42M |
| Net investment purchase and sale | ---- | ---- | ---- | ---- | -122.64%-12K | -98.03%53K | 189.10%2.69M | ---3.02M | ---- | ---682K |
| Net other investing changes | ---- | ---- | -338.89%-79K | -50.00%-18K | ---12K | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -148.86%-81.86M | -169.96%-32.89M | -1,130.71%-12.18M | -410.31%-990K | -252.73%-194K | -103.28%-55K | 125.90%1.68M | 41.64%-6.48M | 68.75%-11.1M | -110.19%-35.53M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -99.90%104K | 405.33%106.47M | 19,976.42%21.07M | -100.89%-106K | -19.40%11.88M | 1,114.10%14.75M | 69.37%-1.45M | -124.56%-4.75M | 2.04%19.33M | -37.22%18.94M |
| Net issuance payments of debt | 125.00%1K | -33.33%-4K | 93.75%-3K | -109.28%-48K | 103.15%517K | -1,871.75%-16.41M | 81.91%-832K | -254.23%-4.6M | -83.64%2.98M | 224.13%18.22M |
| Net common stock issuance | -99.90%103K | 405.27%106.47M | 36,431.03%21.07M | -100.51%-58K | -63.66%11.37M | --31.28M | ---- | ---- | 919.19%16.57M | -96.84%1.63M |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | 79.58%-127K | -320.27%-622K | 34.22%-148K | 75.19%-225K | 86.31%-907K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -99.90%104K | 405.33%106.47M | 19,976.42%21.07M | -100.89%-106K | -19.40%11.88M | 1,114.10%14.75M | 69.37%-1.45M | -124.56%-4.75M | 2.04%19.33M | -37.22%18.94M |
| Net cash flow | ||||||||||
| Beginning cash position | 365.41%99.85M | 182.97%21.46M | 13.15%7.58M | -43.85%6.7M | 126.51%11.94M | -55.94%5.27M | 24.30%11.96M | 155.95%9.62M | -84.96%3.76M | 89.96%24.99M |
| Current changes in cash | -215.58%-90.6M | 463.31%78.38M | 1,369.38%13.92M | 116.93%947K | -183.97%-5.59M | 199.45%6.66M | -387.96%-6.7M | -60.42%2.33M | 127.62%5.88M | -323.37%-21.28M |
| Effect of exchange rate changes | -700.00%-90K | 135.71%15K | 36.36%-42K | -118.38%-66K | 7,080.00%359K | -37.50%5K | -33.33%8K | 185.71%12K | -130.43%-14K | -98.05%46K |
| End cash Position | -90.82%9.17M | 365.41%99.85M | 182.97%21.46M | 13.15%7.58M | -43.85%6.7M | 126.51%11.94M | -55.94%5.27M | 24.30%11.96M | 155.95%9.62M | -84.99%3.76M |
| Free cash from | -221.31%-90.7M | -285.00%-28.23M | -818.12%-7.33M | 105.84%1.02M | -108.71%-17.48M | 0.56%-8.37M | -183.45%-8.42M | 175.00%10.09M | 66.25%-13.45M | -102.73%-39.86M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |